RxDoctor Payments Data

Robin Patel

Medical Microbiology · Rochester, MNNPI 1871573212

Payments from drug & device makers

$446,063in general payments, 2019–2025

Across 41 payments — averaging $10,880 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biofire Diagnostics, LLC$248K
  • Paratek Pharmaceuticals, Inc.$131K
  • Merck$32K
  • Tetraphase Pharmaceuticals, Inc.$13K
  • Shionogi Inc$13K
  • Accelerate Diagnostics Inc.$5K
  • plus $5K from 2 others
$263,212in research payments, 2019–2025

Across 19 payments — averaging $13,853 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biofire Diagnostics, LLC$157K
  • Biomerieux Inc$106K

What the payments were for

  • Consulting fees$5,00055%
  • Speaking & faculty fees$2,40026%
  • Travel & lodging$1,73619%

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biofire Diagnostics, LLC17$247,819
Paratek Pharmaceuticals, Inc.4$130,620
Merck6$31,986
Tetraphase Pharmaceuticals, Inc.2$12,501
Shionogi Inc1$12,501
Accelerate Diagnostics Inc.7$5,236
Biomerieux Inc3$3,900
Abbott1$1,500

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few medical microbiology providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Other medical microbiology in Rochester

Where these figures come from

Is this you, or does something look wrong? →